Page last updated: 2024-11-05

trigonelline and Central Nervous System Disease

trigonelline has been researched along with Central Nervous System Disease in 2 studies

trigonelline: in hydra among other organisms; RN given refers to hydroxide inner salt; structure
N-methylnicotinic acid : A pyridinium ion consisting of nicotinic acid having a methyl substituent on the pyridine nitrogen.
N-methylnicotinate : An iminium betaine that is the conjugate base of N-methylnicotinic acid, arising from deprotonation of the carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Trigonelline has hypoglycemic, hypolipidemic, neuroprotective, antimigraine, sedative, memory-improving, antibacterial, antiviral, and anti-tumor activities, and it has been shown to reduce diabetic auditory neuropathy and platelet aggregation."6.48Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. ( Chan, L; Zhou, J; Zhou, S, 2012)
"Trigonelline has hypoglycemic, hypolipidemic, neuroprotective, antimigraine, sedative, memory-improving, antibacterial, antiviral, and anti-tumor activities, and it has been shown to reduce diabetic auditory neuropathy and platelet aggregation."2.48Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. ( Chan, L; Zhou, J; Zhou, S, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lin, SX1
Curtis, MA1
Sperry, J1
Zhou, J1
Chan, L1
Zhou, S1

Reviews

2 reviews available for trigonelline and Central Nervous System Disease

ArticleYear
Pyridine alkaloids with activity in the central nervous system.
    Bioorganic & medicinal chemistry, 2020, 12-15, Volume: 28, Issue:24

    Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants;

2020
Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease.
    Current medicinal chemistry, 2012, Volume: 19, Issue:21

    Topics: Alkaloids; Animals; Central Nervous System Diseases; Diabetes Mellitus; Humans; Hypoglycemic Agents;

2012